A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans-Reference-Cited by-同舟云学术

A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans

Published:2023-08-25 Issue:9 Volume:87 Page:1229-1237
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Fujioka Ayumu¹,Yanishi Kenji¹,Yukawa Arito¹,Imai Kojiro²,Yokota Isao³,Fujikawa Kei⁴,Yamada Ayumu⁵,Naito Akari⁵,Shoji Keisuke¹,Kawamata Hirofumi¹,Higashi Yukihito⁶,Ishigami Tomoaki⁷,Sasaki Ken-ichiro⁸,Tara Syuhei⁹,Kuwahara Koichiro¹⁰,Teramukai Satoshi⁴,Matoba Satoaki¹

Affiliation:

1. Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine

2. Department for Medical Innovation and Translational Medical Science, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

3. Department of Biostatistics, Graduate School of Medicine, Hokkaido University

4. Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

5. The Clinical and Translational Research Center, University Hospital, Kyoto Prefectural University of Medicine

6. Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University

7. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine

8. Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine

9. Department of Cardiovascular Medicine, Nippon Medical School of Medicine

10. Department of Cardiovascular Medicine, Shinshu University School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/9/87_CJ-23-0046/_pdf

Reference24 articles.

1. 1. Shionoya S. Buerger’s disease: Diagnosis and management. Cardiovasc Surg 1993; 1: 207–214, doi:10.1177/096721099300100302.

2. 2. Watanabe Y, Miyata T, Shigematsu K, Tanemoto K, Nakaoka Y, Harigai M. Current trends in epidemiology and clinical features of thromboangiitis obliterans in Japan. Circ J 2020; 84: 1786–1796, doi:10.1253/circj.CJ-19-1165.

3. 3. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Batholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger’s disease). Circulation 1990; 82(Suppl): IV3–IV8.

4. 4. Shigematsu H, Shigematsu K. Factors affecting the long-term outcome of Buerger’s disease (thromboangiitis obliterans). Int Angiol 1999; 18: 58–64.

5. 5. Sugimoto M, Miyachi H, Morimae H, Kodama A, Narita H, Banno H, et al. The fate of ischemic limbs in patients with Buerger’s disease based on our 30-year experience: Does smoking have a deﬁnitive impact on the late loss of limbs? Surg Today 2015; 45: 466–470, doi:10.1007/s00595-014-0904-6.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-intensity pulsed ultrasound improves symptoms in patients with Buerger disease: a double-blinded, randomized, and placebo-controlled study;Scientific Reports;2024-06-14

2. A scope systematic review to clarify immune response to tobacco in Buerger;2024-03-28

3. Prognostic Predictors After Bone Marrow-Derived Mononuclear Cell Implantation in No-Option Chronic Limb-Threatening Ischemia Patients with Atherosclerotic Lower Extremity Artery Disease;2023-10-26

4. Mesenchymal Stem/Stromal Cells for Therapeutic Angiogenesis;Cells;2023-08-28

5. Therapeutic Angiogenesis for Thromboangiitis Obliterans;Circulation Journal;2023-08-25